Showing results (1201-1210 of 1,364) with videos related to
Sort By:
Pageof 137
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 14, 2007
Prediction of symptom remission in schizophrenia during inpatient treatmentMarkus Jäger, Michael Riedel, Max Schmauss, et al.The American Journal of Pathology|November 15, 2011
BACE2 expression increases in human neurodegenerative diseaseChristopher J Holler, Robin L Webb, Ashley L Laux, et al.Scientific Data|November 10, 2025
A large, paired dataset of robotic and handheld lumbar spine ultrasound with ground-truth CT benchmarkingNicola A Cavalcanti, Ruixuan Li, Laura Arango, et al.The EMBO Journal|July 26, 2003
Impaired insulin secretion and glucose tolerance in beta cell-selective Ca(v)1.2 Ca2+ channel null miceVerena Schulla, Erik Renström, Robert Feil, et al.Psychopathology|July 17, 2012
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating ScaleRebecca Schennach, Michael Obermeier, Florian Seemüller, et al.Epilepsia|July 13, 2018
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program resultsJerzy P Szaflarski, Elizabeth Martina Bebin, Anne M Comi, et al.Archives of Disease in Childhood|November 13, 2025
Cause of death in children with heart disease: a cohort studyNeil Derridj, Daphné Madec, Olivier Raisky, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?R Schennach, M Riedel, M Obermeier, et al.Elife|February 5, 2021
Dyshomeostatic modulation of Ca<sup>2+</sup>-activated K<sup>+</sup> channels in a human neuronal model of KCNQ2 encephalopathyDina Simkin, Kelly A Marshall, Carlos G Vanoye, et al.Pageof 137